Related Experiment Video
Updated: Mar 17, 2026

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
Published on: December 9, 2021
Regulation of Thrombin-Induced Lung Endothelial Cell Barrier Disruption by Protein Kinase C Delta
Lishi Xie1,2, Eddie T Chiang3, Xiaomin Wu3
1Institute for Personalized Respiratory Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Abstract:
Protein Kinase C (PKC) plays a significant role in thrombin-induced loss of endothelial cell (EC) barrier integrity; however, the existence of more than 10 isozymes of PKC and tissue-specific isoform expression has limited our understanding of this important second messenger in vascular homeostasis. In this study, we show that PKCδ isoform promotes thrombin-induced loss of human pulmonary artery EC barrier integrity, findings substantiated by PKCδ inhibitory studies (rottlerin), dominant negative PKCδ construct and PKCδ silencing (siRNA). In addition, we identified PKCδ as a signaling mediator upstream of both thrombin-induced MLC phosphorylation and Rho GTPase activation affecting stress fiber formation, cell contraction and loss of EC barrier integrity. Our inhibitor-based studies indicate that thrombin-induced PKCδ activation exerts a positive feedback on Rho GTPase activation and contributes to Rac1 GTPase inhibition. Moreover, PKD (or PKCμ) and CPI-17, two known PKCδ targets, were found to be activated by PKCδ in EC and served as modulators of cytoskeleton rearrangement. These studies clarify the role of PKCδ in EC cytoskeleton regulation, and highlight PKCδ as a therapeutic target in inflammatory lung disorders, characterized by the loss of barrier integrity, such as acute lung injury and sepsis.
Insights
Protein Kinase C delta (PKCδ) worsens endothelial cell barrier dysfunction during thrombin exposure. This isoform regulates cytoskeleton dynamics, offering a potential therapeutic target for lung injury and sepsis.
Area of Science:
- Biochemistry
- Cell Biology
- Physiology
Background:
- Protein Kinase C (PKC) isozymes regulate endothelial cell (EC) barrier function.
- Understanding specific PKC isoform roles in vascular homeostasis is crucial.
Purpose of the Study:
- To elucidate the role of the PKCδ isoform in thrombin-induced loss of human pulmonary artery EC barrier integrity.
- To identify downstream signaling pathways regulated by PKCδ in ECs.
Main Methods:
- Inhibitory studies using rottlerin.
- Expression of dominant-negative PKCδ construct.
- PKCδ silencing via siRNA.
- Assessment of MLC phosphorylation and Rho GTPase activation.
- Analysis of cytoskeleton rearrangement and EC barrier function.
Main Results:
- PKCδ isoform was identified as a key mediator promoting thrombin-induced EC barrier loss.
- PKCδ activation positively feedbacks on Rho GTPase and inhibits Rac1 GTPase.
- PKCδ targets, PKD (PKCμ) and CPI-17, were activated and modulated EC cytoskeleton.
Conclusions:
- PKCδ plays a critical role in regulating EC cytoskeleton and barrier integrity.
- PKCδ is a potential therapeutic target for inflammatory lung disorders like acute lung injury and sepsis.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway
Clot Retraction and Fibrinolysis
Amplifying Signals via Enzymatic Cascade
cAMP-dependent Protein Kinase Pathways

